Whether you're well steeped in Foolishness or at the beginning stages of your investing journey, these are nine foundational truths not to be forgotten.
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match.
The flip side though is that these lofty expectations make them particularly susceptible to drawdowns when market sentiment shifts.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.
New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government shutdown and a disappointing jobs report. As investors sought refuge in defensive plays and reacted to
The U.S. labor market continues to defy expectations, with the latest Job Openings and Labor Turnover Survey (JOLTS) report for August 2025, released on September 30, 2025, revealing a persistent tightness that could complicate the Federal Reserve's carefully laid plans for interest rate reductions. While some indicators suggest a
New York, NY – September 30, 2025 – The U.S. labor market demonstrated surprising resilience today with the release of the Job Opening and Labor Turnover Survey (JOLTS) report, revealing a robust 7.23 million job openings in September, significantly surpassing the estimated 7.1 million. This unexpected strength in labor
